What is Huna AI?
Founded in 2022, Huna AI operates at the intersection of machine learning and oncology. The company specializes in analyzing routine blood test data to assess cancer risk, with a primary focus on breast cancer detection. By identifying subtle, non-obvious patterns in standard clinical results, Huna AI provides a non-invasive, scalable alternative to traditional screening methods. The company is currently evolving its platform to support a multi-cancer diagnostic framework, positioning itself as a critical player in the preventative health tech sector.
How much funding has Huna AI raised?
Huna AI has raised a total of $1.5M across 1 funding round:
Angel/Pre-Seed
$1.5M
Angel/Pre-Seed (2025): $1.5M with participation from New Ventures Capital, Niu Ventures, Big Bets, and Kortex Ventures
Key Investors in Huna AI
New Ventures Capital
New Ventures Capital is an impact-focused fund manager that supports mission-driven entrepreneurs across Latin America, specializing in market-based solutions for social and environmental challenges.
Niu Ventures
Niu Ventures is a pre-seed venture capital firm based in Brazil that bridges the gap between Latin American startups and the global venture capital landscape, providing mentorship and operational expertise.
Big Bets
Big Bets VC is a venture capital firm that partners with visionary founders to invest in transformative technology companies, with a specific focus on high-impact sectors like health tech and gaming.
What's next for Huna AI?
The recent influx of capital will be directed toward two primary strategic objectives: the expansion of existing product availability and the acceleration of its research and development portfolio. Huna AI intends to leverage these resources to refine its algorithms and broaden the scope of its multi-cancer diagnostics platform. As the company scales, it will likely focus on integrating its technology into broader clinical workflows, thereby enhancing its market footprint and establishing a robust ecosystem for early-stage disease detection. This growth trajectory suggests a shift toward enterprise-level partnerships with healthcare providers and diagnostic laboratories.
See full Huna AI company page
